| Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy K Charizanis, KY Lee, R Batra, M Goodwin, C Zhang, Y Yuan, L Shiue, ... Neuron 75 (3), 437-450, 2012 | 393 | 2012 |
| Elimination of toxic microsatellite repeat expansion RNA by RNA-targeting Cas9 R Batra, DA Nelles, E Pirie, SM Blue, RJ Marina, H Wang, IA Chaim, ... Cell 170 (5), 899-912. e10, 2017 | 304 | 2017 |
| Receptor tyrosine kinase EphB4 is a survival factor in breast cancer SR Kumar, J Singh, G Xia, V Krasnoperov, L Hassanieh, EJ Ley, ... The American journal of pathology 169 (1), 279-293, 2006 | 230 | 2006 |
| EphB4 expression and biological significance in prostate cancer G Xia, SR Kumar, R Masood, S Zhu, R Reddy, V Krasnoperov, DI Quinn, ... Cancer research 65 (11), 4623-4632, 2005 | 207 | 2005 |
| Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF‐C autocrine loops R Masood, A Kundra, ST Zhu, G Xia, P Scalia, DL Smith, PS Gill International journal of cancer 104 (5), 603-610, 2003 | 193 | 2003 |
| Ataxia T Ashizawa, G Xia Continuum: Lifelong Learning in Neurology 22 (4), 1208-1226, 2016 | 172 | 2016 |
| Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study T Ashizawa, KP Figueroa, SL Perlman, CM Gomez, GR Wilmot, ... Orphanet journal of rare diseases 8, 1-8, 2013 | 168 | 2013 |
| Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer G Xia, SR Kumar, D Hawes, J Cai, L Hassanieh, S Groshen, S Zhu, ... The Journal of urology 175 (4), 1245-1252, 2006 | 168 | 2006 |
| RAN translation regulated by muscleblind proteins in myotonic dystrophy type 2 T Zu, JD Cleary, Y Liu, M Bañez-Coronel, JL Bubenik, F Ayhan, ... Neuron 95 (6), 1292-1305. e5, 2017 | 149 | 2017 |
| Impeding transcription of expanded microsatellite repeats by deactivated Cas9 BS Pinto, T Saxena, R Oliveira, HR Méndez-Gómez, JD Cleary, LT Denes, ... Molecular cell 68 (3), 479-490. e5, 2017 | 134 | 2017 |
| EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival G Xia, SR Kumar, JP Stein, J Singh, V Krasnoperov, S Zhu, L Hassanieh, ... Oncogene 25 (5), 769-780, 2006 | 134 | 2006 |
| Depression and clinical progression in spinocerebellar ataxias RY Lo, KP Figueroa, SM Pulst, S Perlman, G Wilmot, C Gomez, ... Parkinsonism & related disorders 22, 87-92, 2016 | 120 | 2016 |
| Requirement of Notch 1 and its ligand jagged 2 expressions for spermatogenesis in rat and human testes T HAYASHI, Y KAGEYAMA, K ISHIZAKA, G XIA, K KIHARA, H OSHIMA Journal of andrology 22 (6), 999-1011, 2001 | 107 | 2001 |
| EphB4 provides survival advantage to squamous cell carcinoma of the head and neck R Masood, SR Kumar, UK Sinha, DL Crowe, V Krasnoperov, RK Reddy, ... International Journal of Cancer 119 (6), 1236-1248, 2006 | 99 | 2006 |
| Regulation of vascular endothelial growth factor transcription by endothelial PAS domain protein 1 (EPAS1) and possible involvement of EPAS1 in the angiogenesis of renal cell … G Xia, Y Kageyama, T Hayashi, S Kawakami, M Yoshida, K Kihara Cancer: Interdisciplinary International Journal of the American Cancer …, 2001 | 75 | 2001 |
| Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium R Masood, G Xia, DL Smith, P Scalia, JG Still, A Tulpule, PS Gill Blood 105 (3), 1310-1318, 2005 | 73 | 2005 |
| Expression of aquaporins 7 and 8 in the developing rat testis Y Kageyama, K Ishibashi, T Hayashi, G Xia, S Sasaki, K Kihara Andrologia 33 (3), 165-169, 2001 | 73 | 2001 |
| Up-regulation of EphB4 in mesothelioma and its biological significance G Xia, SR Kumar, R Masood, M Koss, C Templeman, D Quinn, S Zhu, ... Clinical cancer research 11 (12), 4305-4315, 2005 | 71 | 2005 |
| ATXN2‐AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis PP Li, X Sun, G Xia, N Arbez, S Paul, S Zhu, HB Peng, CA Ross, ... Annals of neurology 80 (4), 600-615, 2016 | 70 | 2016 |
| Therapeutic genome editing for myotonic dystrophy type 1 using CRISPR/Cas9 Y Wang, L Hao, H Wang, K Santostefano, A Thapa, J Cleary, H Li, X Guo, ... Molecular Therapy 26 (11), 2617-2630, 2018 | 69 | 2018 |
